124 results on '"Sciandra F"'
Search Results
2. SAFETY MATTERS: THE TROUBLED AND FINALLY SUCCESSFUL STORY OF DIHYDROPYRIMIDINE DEHYDROGENASE PHARMACOGENETIC TEST IN CANCER PATIENTS
3. Modeling and molecular dynamics of α-dystroglycanʼs C-terminus reveals the presence of an Ig-like domain encompassing its β-dystroglycan binding epitope: C3.15
4. First genetic analysis of lattice corneal dystrophy type I in a family from Bulgaria
5. A dystroglycan mutation (p.Cys66uPhe) associated to muscle-eye-brain disease with multicystic leukodystrophy results in ER-retention of the mutant protein
6. Structural flexibility of human α-dystroglycan
7. optical nanoscopy applied to the characterization of maturation and localization of defective dystroglycan mutants
8. Crystal structure of the D109N mutant of the mouse alpha-Dystroglycan N-terminal region
9. Crystal structure of the V72I mutant of the mouse alpha-Dystroglycan N-terminal region
10. The enzymatic processing of α-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site
11. α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis
12. Crystal structure of human alpha-dystroglycan
13. Immunostaining of the sarcolemma with a new monoclonal antibody against alpha-dystroglycan core and its relevance to diagnosis
14. Alpha Dystroglycan monoclonal antibodies
15. FRAP analysis of dystroglycan, a membrane receptor involved in congenital muscular dystrophies
16. Il Distroglicano, un recettore coinvolto nelle distrofie muscolari: dalla biochimica cellulare ad un modello murino
17. MicroRnas involved in human peripheral blood leukocytes reaction to coronary angiography and angioplasty with drug eluting stent positioning
18. MicroRNA from human peripheral blood leukocytes and cardiovascular diseases
19. Assessing the role of the ±/²-dystroglycan interface for the processing and maturation of the dystroglycan precursor
20. The structure of Murine alpha-Dystroglycan T190M mutant N-terminal domain.
21. Is dystroglycan, a membrane receptor involved in muscular dystrophies, a target of the disulphide isomerase ERp57?
22. Analysis of the enzymatic activity of MMP-9 and MMP-2 on the recombinant domains of dystroglycan
23. G.P.321
24. Analysis at the molecular level of the interaction between ±-dystroglycan and ²-dystroglycan and assessment of its implication for skeletal muscle physiopathology
25. Structural and functional aspects of dystroglycan: towards the elucidation of its pathophysiological role
26. MicroRNAs in human blood leukocytes and coronary angioplasy
27. Structural and functional aspects of dystroglycan:towards the elucidation of its pathophysiological role
28. Functional diversity of dystroglycan
29. alpha and beta dystroglycan: evaluation of processing and targeting through multiple fluorescent tagging
30. Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor
31. ±- and ²-dystroglycan: evaluation of processing and targeting through multiple fluorescent tagging
32. The human keratoepithelin FAS1-4 domain as a model for the study of protein misfolding and amyloidogenesis: recombinant expression and preliminary characterisation
33. Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies
34. Biochemical and cellular analysis of the dystroglycan alpha/beta interface
35. Identification of the MMP-9 cleavage site on the recombinant b-dystroglycan ectodomain
36. First molecular characterization and immunolocalization of keratoepithelin in adult human skeletal muscle
37. Immunological dissection of the human dystroglycan complex
38. Genetic analysis of the dystroglycan gene in bronchopulmonary dysplasia affected premature newborns
39. Analysis of dystroglycan in human patients affected by neuromuscular disorders.Analysis of dystroglycan in human patients affected by neuromuscular disorders
40. Mutagenesis of the ±- and ²- dystroglycan interface
41. Genetic analysis of the dystroglycan gene in brochopulmnary dysplasia affected premature newbors
42. Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?
43. Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro
44. Analysis at the molecular level of the interaction between alfa-dystroglycan and beta-dystroglycan
45. Immunodetection of partially glycosylated isoforms of alpha-dystroglycan by a new monoclonal antibody against its beta-dystroglycan-binding epitope
46. alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy
47. The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture
48. Expression and localization of dystroglycan in human gliomas
49. Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan
50. P.1.17 Immunostaining of the sarcolemma with a new monoclonal antibody against alpha-dystroglycan core and its relevance to diagnosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.